NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Medicines Update

For all prescribers and health professionals both in primary care and the acute sector.

News and information blog from ADTC covering clinical topics for all sectors of the NHS.

All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site.  Click here for an index to all previous editions.  If you would like a copy of a previous edition, please contact  medicines.update@ggc.scot.nhs.uk

New BNF and BNFC App Launched

Posted: August 09, 2017.
Category - Medicines Update

The publishers of the BNF and BNF for Children (BNFC) have launched a new BNF/BNFC App which will replace the existing NICE BNF and BNFC Apps.

Read More...

Do I really need to prescribe an immediate antibiotic for lower respiratory tract infections?

Posted: July 28, 2017.
Category - Medicines Update

A recent large observational UK general practice study of 28,883 patients with uncomplicated lower respiratory tract infection (RTI) (BMJ 2017; 357:j2148) supports other evidence that there is little to be gained from prescribing immediate anti...

Read More...

Post-MI LVSD Teach and Treat

Posted: July 25, 2017.
Category - Medicines Update

Following agreement between NHS Education Scotland (NES), cardiology and pharmacy services in NHSGGC (September 2013), patients

Read More...

Ticagrelor 60mg

Posted: July 25, 2017.
Category - Medicines Update
Tagged with - Biologics

Following SMC advice that ticagrelor 60mg twice daily is not recommended for use in NHS Scotland, NHSGGC Heart MCN has recommended that the small number of patients currently receiving this should have their prescription changed to clopidogrel ...

Read More...

MHRA Updates May & June 2017

Posted: July 10, 2017.
Category - Medicines Update
Tagged with - MHRA Drug Safety Update

Drug Safety Update (June 2017) includes: Denosumab (Prolia, Xgeva ▼): reports of osteone...

Read More...

New lipid lowering medicines: Alirocumab and evolocumab

Posted: July 03, 2017.
Category - Medicines Update
Tagged with - Formulary

Two new lipid lowering medicines, alirocumab and evolocumab (PCSK9 inhibitors) are on the GGC Formulary for initiation by specialist lipid clinics. Use is restrict...

Read More...

Alogliptin: DPP-4 Inhibitor of Choice

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Diabetes

The position of alogliptin in the NHSGGC Formulary has changed.  The previous prescribing restriction limiting use in dual therapy has been remov...

Read More...

Fast acting insulin aspart

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Diabetes

Fast acting Insulin aspart (Fiasp®) has been accepted by the SMC and added to the Formulary. It is a modified formulation of insulin aspart with the property of more rapid absorption of insulin from subcutaneous injection site than standard...

Read More...

Tiotropium: Braltus Zonda

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Respiratory

In April 2017, the ADTC accepted the Respiratory MCN’s recommendation on tiotropium inhaler devices. Braltus® Zonda Inhaler is now the preferred brand of tiotropium inhaler. Spiriva Respimat® remains a Total Formulary option. ...

Read More...

Butec (buprenorphine) patch

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Opioids

Butec® is the NHSGGC preferred brand of buprenorphine 7 day transdermal patch across primary and secondary care. It is restricted to specialist use only in elderly patients (over 65 years) where standard analgesic options are ineffective or...

Read More...